Early-life RSV infection and parental allergy interact to substantially increase childhood asthma risk, supported by ...

Key points A 62-year-old man with hypertension and chronic renal disease presented to an emergency department with abdominal ...

Early-life viral infection programs immune cells to hijack allergy-associated maternal antibodies, driving allergy risk later ...

It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.

Researchers evaluated the real-world effectiveness of nirsevimab in preventing ICU admission and acute respiratory failure associated with RSV among infants.

Recovering from respiratory syncytial virus often doesn't end when it's time to leave the hospital, even for younger adults.

An infection with respiratory syncytial virus (RSV) typically affects infants much harder than adults. While adults usually ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

FDA reexamine infant RSV therapies with Sanofi, AstraZeneca, and Merck amid safety concerns and data review under new FDA leadership.

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations to face scrutiny under Health Secretary RFK, Jr.

The FDA is reviewing the safety of two drugs, Clesrovimab and Nirsevimab, which are approved for the prevention of RSV in infants and toddlers, and are 80-90% effective at reducing the risk of ...